BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31848674)

  • 1. Binding of [
    Schaeverbeke J; Celen S; Cornelis J; Ronisz A; Serdons K; Van Laere K; Thal DR; Tousseyn T; Bormans G; Vandenberghe R
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1949-1960. PubMed ID: 31848674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flortaucipir tau PET imaging in semantic variant primary progressive aphasia.
    Makaretz SJ; Quimby M; Collins J; Makris N; McGinnis S; Schultz A; Vasdev N; Johnson KA; Dickerson BC
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1024-1031. PubMed ID: 28986472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct [
    Schaeverbeke J; Evenepoel C; Declercq L; Gabel S; Meersmans K; Bruffaerts R; Adamczuk K; Dries E; Van Bouwel K; Sieben A; Pijnenburg Y; Peeters R; Bormans G; Van Laere K; Koole M; Dupont P; Vandenberghe R
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2342-2357. PubMed ID: 29946950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of pathology in primary progressive language and speech disorders.
    Deramecourt V; Lebert F; Debachy B; Mackowiak-Cordoliani MA; Bombois S; Kerdraon O; Buée L; Maurage CA; Pasquier F
    Neurology; 2010 Jan; 74(1):42-9. PubMed ID: 19940270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [
    Blazhenets G; Soleimani-Meigooni DN; Thomas W; Mundada N; Brendel M; Vento S; VandeVrede L; Heuer HW; Ljubenkov P; Rojas JC; Chen MK; Amuiri AN; Miller Z; Gorno-Tempini ML; Miller BL; Rosen HJ; Litvan I; Grossman M; Boeve B; Pantelyat A; Tartaglia MC; Irwin DJ; Dickerson BC; Baker SL; Boxer AL; Rabinovici GD; La Joie R
    J Nucl Med; 2023 Dec; 64(12):1980-1989. PubMed ID: 37918868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Typical and atypical pathology in primary progressive aphasia variants.
    Spinelli EG; Mandelli ML; Miller ZA; Santos-Santos MA; Wilson SM; Agosta F; Grinberg LT; Huang EJ; Trojanowski JQ; Meyer M; Henry ML; Comi G; Rabinovici G; Rosen HJ; Filippi M; Miller BL; Seeley WW; Gorno-Tempini ML
    Ann Neurol; 2017 Mar; 81(3):430-443. PubMed ID: 28133816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau accumulation in two patients with frontotemporal lobe degeneration showing different types of aphasia using 18F-THK-5351 positron emission tomography: a case report.
    Takaya M; Ishii K; Hosokawa C; Saigoh K; Shirakawa O
    Int Psychogeriatr; 2018 May; 30(5):641-646. PubMed ID: 29113604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progressive nonfluent aphasia].
    Murayama S; Saito Y
    Brain Nerve; 2011 Oct; 63(10):1037-46. PubMed ID: 21987561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological fingerprints of survival, atrophy and language in primary progressive aphasia.
    Mesulam MM; Coventry CA; Bigio EH; Sridhar J; Gill N; Fought AJ; Zhang H; Thompson CK; Geula C; Gefen T; Flanagan M; Mao Q; Weintraub S; Rogalski EJ
    Brain; 2022 Jun; 145(6):2133-2148. PubMed ID: 35441216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent patterns of TDP-43 and tau pathologies in primary progressive aphasia.
    Giannini LAA; Xie SX; McMillan CT; Liang M; Williams A; Jester C; Rascovsky K; Wolk DA; Ash S; Lee EB; Trojanowski JQ; Grossman M; Irwin DJ
    Ann Neurol; 2019 May; 85(5):630-643. PubMed ID: 30851133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicoradiological and neuropathological evaluation of primary progressive aphasia.
    Shir D; Corriveau-Lecavalier N; Bermudez Noguera C; Barnard L; Pham NTT; Botha H; Duffy JR; Clark HM; Utianski RL; Knopman DS; Petersen RC; Boeve BF; Murray ME; Nguyen AT; Reichard RR; Dickson DW; Day GS; Kremers WK; Graff-Radford NR; Jones DT; Machulda MM; Fields JA; Whitwell JL; Josephs KA; Graff-Radford J
    J Neurol Neurosurg Psychiatry; 2024 Mar; ():. PubMed ID: 38514176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue.
    Marquié M; Normandin MD; Vanderburg CR; Costantino IM; Bien EA; Rycyna LG; Klunk WE; Mathis CA; Ikonomovic MD; Debnath ML; Vasdev N; Dickerson BC; Gomperts SN; Growdon JH; Johnson KA; Frosch MP; Hyman BT; Gómez-Isla T
    Ann Neurol; 2015 Nov; 78(5):787-800. PubMed ID: 26344059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo staging of frontotemporal lobar degeneration TDP-43 type C pathology.
    Bocchetta M; Iglesias Espinosa MDM; Lashley T; Warren JD; Rohrer JD
    Alzheimers Res Ther; 2020 Mar; 12(1):34. PubMed ID: 32220237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of semantic variant primary progressive aphasia with Pick's pathology.
    Caplan A; Marx G; Elofson J; Lis C; Grinberg L; Miller B; Rosen H
    Neurocase; 2018 Apr; 24(2):90-94. PubMed ID: 29508660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontotemporal lobar degeneration: diversity of FTLD lesions.
    Seilhean D; Bielle F; Plu I; Duyckaerts C
    Rev Neurol (Paris); 2013 Oct; 169(10):786-92. PubMed ID: 24035575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head to head comparison of [
    Jang YK; Lyoo CH; Park S; Oh SJ; Cho H; Oh M; Ryu YH; Choi JY; Rabinovici GD; Kim HJ; Moon SH; Jang H; Lee JS; Jagust WJ; Na DL; Kim JS; Seo SW
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):432-442. PubMed ID: 29143870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathological features of sporadic frontotemporal lobar degeneration with TDP-43-positive inclusions].
    Yokota O
    Rinsho Shinkeigaku; 2010 Nov; 50(11):1018-21. PubMed ID: 21921551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological characterization of Pick's disease versus frontotemporal lobar degeneration with ubiquitin/TDP-43-positive inclusions.
    Yokota O; Tsuchiya K; Arai T; Yagishita S; Matsubara O; Mochizuki A; Tamaoka A; Kawamura M; Yoshida H; Terada S; Ishizu H; Kuroda S; Akiyama H
    Acta Neuropathol; 2009 Apr; 117(4):429-44. PubMed ID: 19194716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum.
    Meeter LHH; Vijverberg EG; Del Campo M; Rozemuller AJM; Donker Kaat L; de Jong FJ; van der Flier WM; Teunissen CE; van Swieten JC; Pijnenburg YAL
    Neurology; 2018 Apr; 90(14):e1231-e1239. PubMed ID: 29514947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
    Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
    J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.